Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers

Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.

V V Kakkar, B Djazaeri, Jonathan Fok et al. · BMJ · 1982 · 174 citations · Full text

Medicine, Hematology, Surgery +17

Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits

E. Holmer, Christer Mattsson, Solveig Nilsson · Thrombosis Research · 1982 · 164 citations

Medicine, Hematology, Hemostasis +10

A Comparison Between Low Molecular Weight Heparin (KABI 2165) and Standard Heparin in the Intravenous Treatment of Deep Venous Thrombosis

Göran Bratt, E. Törnebohm, S. Granqvist et al. · Thrombosis and Haemostasis · 1985 · 159 citations

Medicine, Hematology, Pharmacology +14

An objective study of alternative methods of heparin administration

P G Bentley, Vijay V. Kakkar, Michael Scully et al. · Thrombosis Research · 1980 · 127 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +6

Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously

David Bergqvist, Ulla Hedner, Elsy Sjörin et al. · Thrombosis Research · 1983 · 120 citations

Medicine, Hematology, Pharmacology +12